Literature DB >> 35852689

Antimicrobial Activity of the Serum before and after Vaccination with EpiVacCorona.

V G Arzumanyan1, E P Bystritskaya2, T I Kolyganova2,3, A M Iksanova2, P V Samoilikov2, S Yu Konanykhina2, A A Vartanova2, O A Svitich2,3.   

Abstract

We evaluated the effect of vaccination with anti-COVID-19 vaccine EpiVacCorona on serum antimicrobial activity, formation of specific IgG antibodies, and expression of some antimicrobial peptides. Antimicrobial activity of the serum from 55 volunteers towards S. aureus cells was measured spectrophotometrically; IgG-antibodies against SARS-CoV-2 antigen were assayed by ELISA; expression of genes encoding antimicrobial peptides LL37, HBD1, and HBD2 was evaluated by PCR with reverse transcription. Total antimicrobial serum activity and activity of its low-molecular-weight fraction containing antimicrobial peptides demonstrated an inverse correlation. Both activities after vaccination increased in case of low initial values, but decreased in case of high initial values. The vector of change of specific IgG antibodies to coronavirus inversely correlated with the vector of change of activity of antimicrobial peptide fraction. The expression of genes of antimicrobial peptides LL37, HBD1, and HBD2 looked like normal distribution depending on activities of the antimicrobial peptides in the corresponding sera.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  EpiVacCorona; antimicrobial activity; antimicrobial peptides; serum; vaccination

Mesh:

Substances:

Year:  2022        PMID: 35852689      PMCID: PMC9294802          DOI: 10.1007/s10517-022-05548-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  9 in total

1.  Modified method for evaluation of plasma membrane integrity in eukaryotic cell.

Authors:  V G Arzumanyan; I M Ozhovan
Journal:  Bull Exp Biol Med       Date:  2002-07       Impact factor: 0.804

2.  Enhanced Antibacterial Activity of Hen Egg-White Lysozyme against Staphylococcus aureus and Escherichia coli due to Protein Fibrillation.

Authors:  Zhengxun Wei; Sihong Wu; Jiujie Xia; Ping Shao; Peilong Sun; Ning Xiang
Journal:  Biomacromolecules       Date:  2021-01-19       Impact factor: 6.988

3.  Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.

Authors:  Patrick A M Jansen; Diana Rodijk-Olthuis; Edward J Hollox; Marijke Kamsteeg; Geuranne S Tjabringa; Gys J de Jongh; Ivonne M J J van Vlijmen-Willems; Judith G M Bergboer; Michelle M van Rossum; Elke M G J de Jong; Martin den Heijer; Andrea W M Evers; Mieke Bergers; John A L Armour; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

4.  Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.

Authors:  Kazushige Midorikawa; Kazuhisa Ouhara; Hitoshi Komatsuzawa; Toshihisa Kawai; Sakuo Yamada; Tamaki Fujiwara; Kenshi Yamazaki; Koji Sayama; Martin A Taubman; Hidemi Kurihara; Koji Hashimoto; Motoyuki Sugai
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis.

Authors:  Garyfallia Kaltsa; Giorgos Bamias; Spyros I Siakavellas; Dimitris Goukos; Dimitris Karagiannakis; Evanthia Zampeli; Jiannis Vlachogiannakos; Spyridon Michopoulos; Irene Vafiadi; George L Daikos; Spiros D Ladas
Journal:  Ann Gastroenterol       Date:  2016 Jan-Mar

6.  Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms.

Authors:  Jason Kang; Matthew J Dietz; Bingyun Li
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

7.  Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.

Authors:  Regina Geitani; Carole Ayoub Moubareck; Lhousseine Touqui; Dolla Karam Sarkis
Journal:  BMC Microbiol       Date:  2019-03-08       Impact factor: 3.605

8.  Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults.

Authors:  Brian M Dixon; Tyler Barker; Toni McKinnon; John Cuomo; Balz Frei; Niels Borregaard; Adrian F Gombart
Journal:  BMC Res Notes       Date:  2012-10-24

9.  Human antimicrobial peptide, LL-37, induces non-inheritable reduced susceptibility to vancomycin in Staphylococcus aureus.

Authors:  Cathrine Friberg; Jakob Krause Haaber; Martin Vestergaard; Anaëlle Fait; Veronique Perrot; Bruce R Levin; Hanne Ingmer
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.